Summary
The interaction of µ-opioid receptors and G proteins after chronic morphine treatment was investigated in rats. Male Sprague-Dawley rats (200–260 g) were rendered tolerant to morphine by i.p. injections of increasing doses of morphine twice daily for 4 or 6 days. During this period, there was a time-dependent increase in the AD50 values for morphine to inhibit the tail-flick response. In addition, in vitro µ-opioid receptor binding to midbrain P2 membranes from these animals revealed that the ability of 10 μmol/l Gpp(NH)p (guanyl-5′-yl imidodiphosphate) to decrease [3H]DAMGO (TyrD-Ala-Gly-McPhe-Gly-ol) binding affinity, i.e., the ratio K d(+Gpp(NH)p)/K d(−Gpp(NH)p), decreased significantly from the control value of 3.68±0.40 to 2.37±0.35 after 6 days of morphine treatment (P<0.05).
The ability of DAMGO to stimulate low K m GTPase activity was also investigated. The EC50 significantly increased from 2.7± 1.1 × 10−8 mol/l in the control group to 10.8±1.5 × 10−8 mol/l after 4 days of morphine treatment and was further increased to 13.5±2.1 × 10−8 mol/l after 6 days of morphine treatment. The maximal stimulation by DAMGO decreased significantly from 18.0±1.7% to 12.8± 1.6% after 6 days of morphine treatment.
These results indicate that the interaction between µ-opioid receptors and G proteins had been altered after chronic morphine treatment.
Similar content being viewed by others
References
Barchfeld CC, Medzihradsky F (1984) Receptor-mediated stimulation of brain GTPase by opiates in normal and dependent rats. Biochem Biophys Res Commun 121:641–648
Benovic JL, Pike LJ, Cerione RA, Staniszewski C, Yoshimasa T, Codina J, Caron MG, Lefkowitz RJ (1985) Phosphorylation of the mammalian β-adrenergic receptor by cyclic AMP-dependent protein kinase. J Biol Chem 260:7094–7101
Benovic JL, Kuhn H, Weyand I, Codina J, Caron MT, Lefkowitz RJ (1987) Functional desensitization of the isolated β-adrenergic receptor by the β-adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48-kDa protein). Proc Natl Acad Sci USA 84:8879–8882
Blume AJ (1978) Interaction of ligands with the opiate receptors of brain membranes: regulation by ions and nucleotides. Proc Natl Acad Sci USA 75:1713–1717
Burns DL, Hewlett EL, Moss J, Vaughan M (1983) Pertussis toxin inhibits enkephalin stimulation of GTPase of NG108–15 cells. J Biol Chem 258:1435–1438
Cassel D, Selinger Z (1976) Catecholamine-stimulated GTPase activity in turkey erythrocyte membranes. Biochim Biophys Acta 452:538–551
Chang K-J, Hazum E, Killian A, Cuatrecasas P (1981) Interactions of ligands with morphine and enkephalin receptors are differentially affected by guanine nucleotide. Mol Pharmacol 20:1–7
Childers SR, Snyder SH (1980) Differential regulation by guanine nucleotides of opiate agonist and antagonist receptor interactions. J Neurochem 34:583–593
D'Amour FE, Smith DL (1941) A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74–79
Danks JA, Tortella FC, Bykov V, Jacobson AE, Rice KC, Holaday JW, Rothman RB (1988) Chronic administration of morphine and naltrexone up-regulate [3H][d-Ala2, d-Leu5]enkephalin binding sites by different mechanisms. Neuropharmacol 27:965–974
Dixon WJ (1965) The up and down method for small samples. Am Stat Assoc J:967–978
Frances B, Moisand C, Meunier J-C (1985) Na+ ions and Gpp(NH)p selectively inhibit agonist interactions at µ-and κ-opioid receptor sites in rabbit and guinea-pig cerebellum membranes. Eur J Pharmacol 117:223–232
Hitzemann RJ, Hitzemann BA, Loh HH (1974) Binding of [3H] naloxone in the mouse brain: Effect of ions and tolerance development. Life Sci 14:2393–2404
Holaday JW, Hitzemann RJ, Curell J, Tortella FC, Belenky GL (1982) Repeated electroconvulsive shock or chronic morphine treatment increase the number of [3H]-d-Ala2, d-Leu5-enkephalin in binding sites in rat brain membranes. Life Sci 31:2359–2362
Hollt V, Dum J, Blasig J, Schubert P, Herz A (1975). Comparison of in vivo and in vitro parameters of opiate receptor binding in naive and tolerant/dependent rats. Life Sci 16:1823–1828
Klee WA, Streaty RA (1974) Narcotic receptor sites in morphine-dependent rats. Nature 248:61–63
Koski G, Klee WA (1981) Opiates inhibit adenylate cyclase by stimulating GTP hydrolysis. Proc Natl Acad Sci USA 78:4185–4189
Law PY, Hom DS, Loh HH (1982) Loss of opiate receptor activity in Neuroblastoma x Glioma NG108–15 hybrid cells after chronic opiate treatment: a multiple step process. Mol Pharmacol 22:1–4
Law PY, Hom DS, Loh HH (1983) Opiate receptor down-regulation and desensitization in Neuroblastoma x Glioma NG108–15 hybrid cells are two separate cellular adaptation processes. Mol Pharmacol 24:413–424
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265–275
McPherson GA (1983) A practical computer-based approach to the analysis of radioligand binding experiments. Comput Programs Biomed 17:107–114
Munson PJ, Rodbard D (1980) LIGAND: A versatile computerized approach for characterization of ligand binding systems. Anal Biochem 107:220–239
Parenti M, Gazzotti G, Tirone F, Groppetti A (1983) Opiate tolerance and dependence is associated with a decreased activity of GTPase in rat striatal membranes. Life Sci 33, Sup I:345–348
Pert CB, Snyder SH (1976) Opiate receptor binding enhancement by opiate administration in vivo. Biochem Pharmacol 25:847–853
Puttfarcken PS, Werling LL, Cox BM (1988) Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: A useful model for the study of tolerance at µ opioid receptor. Mol Pharmacol 33:520–527
Rogers NF, el-Fakahany E (1986) Morphine-induced opioid receptor down-regulation detected in intact adult rat brain cells. Eur J Pharmacol 124:221–230
Rothman RB, Danks JA, Jacobson AE, Burke TR, Burke TR Jr, Rice KC, Tortella FC, Holaday JW (1986) Morphine tolerance increases mu-noncompetitive delta binding sites. Eur J Pharmacol 124: 113–119
Rothman RB, Bykov V, Long JB, Brady LS, Jacobson AE, Rice KC, Holaday JW (1989) Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H](d-Ala2, McPhe4, Gly-ol5)enkephalin: further evidence for two mu-binding sites. Eur J Pharmacol 160:71–82
Simon EJ, Hiller JB (1978) In vitro studies on opiate receptors and their ligands. Fed Proc 37:141–146
Sumner BE, Coombes JE, Pumford KM, Russell JA (1990) Opioid receptor subtypes in the supraoptic nucleus and posterior pituitary gland of morphine-tolerant rats. Neuroscience 37:635–645
Tao P-L, Law PY, Loh HH (1987) Decrease in σ- and µ-opioid receptor binding capacity in rat brain after chronic etorphine treatment. J Pharmacol Exp Ther 240:809–816
Tao P-L, Chang L-R, Law PY, Loh HH (1988) Decrease in σ-opioid receptor density in rat brain after chronic d-Ala2, d-Leu5-enkephalin treatment. Brain Res 462:313–320
Tao P-L, Lee HY, Chang L-R, Loh HH (1990) Decrease in mu-opioid receptor binding capacity in rat brain after chronic PLO17 treatment. Brain Res 526:270–275
Tao P-L, Tsai C-L, Chang L-R, Loh HH (1991) Chronic effect of (d-Pen2, d-Pen5)enkephalin on rat brain opioid receptors. Eur J Pharmacol 201:209–214
Tempel A, Habas JE, Paredes W, Barr GA (1988) Morphine-induced downregulation of µ-opioid receptors in neonatal rat brain. Brain Res 469:129–133
Vachon L, Costa T, Herz A (1985) Desensitization of opioid-stimulated GTPase in neuroblastoma x glioma hybrid cells. Biochem Biophys Res Commun 128:1342–1349
Vachon L, Costa T, Herz A (1987) GTPase and adenylate cyclase desensitize at different rates in NG108–15 cells. Mol Pharmacol 31:159–168
Werling LL, McMahon PN, Cox BM (1989) Selective changes in mu opioid receptor properties induced by chronic morphine exposure. Proc Natl Acad Sci USA 86:6393–6397
Wilden U, Hall SW, Kuhn H (1986) Phosphodiesterase activation by photoexcited rhodopsin is quenched when rhodopsin is phosphorylated and binds the intrinsic 48-kDa protein of rod outer segments. Proc Natl Acad Sci USA 83:1174–1178
Williams J, North RA (1983) Tolerance to opiates in locus coerulcus actions? Abstr Int Narc Res Conf p 49
Wong C-S, Su Y-F, Watkins WD, Chang K-J (1992) Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes. J Pharmacol Exp Ther 262:317–326
Author information
Authors and Affiliations
Additional information
Correspondence to: P.-L. Tao at the above address
Rights and permissions
About this article
Cite this article
Tao, PL., Lee, CR., Law, PY. et al. The interaction of the mu-opioid receptor and G protein is altered after chronic morphine treatment in rats. Naunyn-Schmiedeberg's Arch Pharmacol 348, 504–508 (1993). https://doi.org/10.1007/BF00173210
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00173210